- Investing Ideas
- Canadian Pharmaceuticals & Biotech High Insider Buying
Canadian Pharmaceuticals & Biotech High Insider Buying
Results
16
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
16 companies
Eupraxia Pharmaceuticals
Market Cap: CA$645.8m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.79
7D
-3.5%
1Y
86.5%
Satellos Bioscience
Market Cap: CA$227.9m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$10.12
7D
-7.8%
1Y
9.5%
Medexus Pharmaceuticals
Market Cap: CA$101.2m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.05
7D
-2.9%
1Y
13.0%
ME Therapeutics Holdings
Market Cap: CA$75.1m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$2.50
7D
0%
1Y
-76.2%
Medicenna Therapeutics
Market Cap: CA$60.5m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.70
7D
-9.1%
1Y
-30.0%
Sona Nanotech
Market Cap: CA$36.6m
Operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.
SONA
CA$0.33
7D
-1.5%
1Y
1.6%
Microbix Biosystems
Market Cap: CA$34.6m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.25
7D
4.2%
1Y
-39.0%
Rubicon Organics
Market Cap: CA$33.5m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.48
7D
-0.5%
1Y
-6.7%
Optimi Health
Market Cap: CA$28.1m
Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.
OPTI
CA$0.29
7D
-1.7%
1Y
52.6%
PharmaCielo
Market Cap: CA$17.0m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.085
7D
30.8%
1Y
54.5%
Marvel Biosciences
Market Cap: CA$10.1m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.15
7D
10.7%
1Y
6.9%
Blueberries Medical
Market Cap: CA$9.9m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.02
7D
100.0%
1Y
100.0%
Christina Lake Cannabis
Market Cap: CA$7.4m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.03
7D
0%
1Y
-40.0%
Simply Solventless Concentrates
Market Cap: CA$6.9m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.065
7D
62.5%
1Y
-90.3%
Restart Life Sciences
Market Cap: CA$6.2m
Through its subsidiaries, operates as a biotechnology company worldwide.
HEAL
CA$0.10
7D
-9.1%
1Y
5.3%
Many Bright Ideas Technologies
Market Cap: CA$345.2k
Does not have significant operations.
MBI.H
CA$0.02
7D
0%
1Y
0%